In the same way, inhibition of this pathway in CCA cell lines with β-catenin siRNA leads to the overcoming of multidrug resistance; this effect is mediated by a reduction in the expression of the multidrug resistance protein (MDR1, P-glycoprotein) [102]. The gene discussed is ABCB1; the disease is cholangiocarcinoma.